By Steve Elliott
South Carolina voters, on a non-binding ballot question in the Democratic Primary, favored the legalizing of marijuana for medical purposes by a whopping 3-to-1 margin, 75 percent to 25 percent, in Tuesday's voting.
Since the referendum question was non-binding, the vote doesn't mean medical marijuana will become legal; it just means Democratic voters were giving direction to their lawmakers.
"Think of it as kind of a general survey," said South Carolina Democratic Party chairman Jaime Harrison, reports John Monk at Myrtle Beach Online. "Our House Democratic Caucus wanted to get a good sense of where Democrats were on those particular issues and how to draw up that legislation."
Rep. James Smith, a Democratic legislator from Columbia, said House Democrats will come up with a medical marijuana bill next year, reports Robert Kittle at WLTX. Smith said medical marijuana was "Obviously overwhelmingly supported in the Democratic Primary, but I hear a lot from independents and Republicans who see that as something we ought to think about," Smith said.
More than 114,000 people voted on the medical marijuana question in the Democratic Primary.
Patient Focused Certification program brings quality, safety standards to medical marijuana industry
Three businesses in Arizona and New Mexico were certified on Wednesday by a new nationwide program that verifies the quality and reliability of medical marijuana produced, analyzed, and sold.
The licensed dispensary Harvest of Tempe was the first licensed medical marijuana business in Arizona to be certified, and AZ Med Testing of Phoenix is the first laboratory in the country to be certified by the PFC program.
The PFC program is a project of Americans for Safe Access (ASA) and the only nonprofit, third-party certification for the medical marijuana industry based on new quality standards issued by the American Herbal Products Association (AHPA) and the American Herbal Pharmacopeia (AHP).
By Steve Elliott
The board of directors of the Colorado Springs, Colorado-based company formerly known as Endocan Corporation, which specializes in cannabis and cannabinoid formulation-based health and wellness solutions, has selected the new name OmniCanna Health Solutions, they announced on Tuesday.
"OmniCanna Health Solutions was chosen by the Board as a direct reference to the latin 'omnis' meaning 'all' and Canna in relation to 'cannabis and cannabinoids'," said Dr. Dorothy Bray, president of OmniCanna Health Solutions, Inc. "The 'health solutions' completes the full meaning and general mission of the Company to provide the wellness solutions using the full spectrum of legal cannabis and cannabinoid extract based products," Dr. Bray said.
The company's website has been changed accordingly to www.omnicanna.com .
According to the company, the name change began with appropriate regulatory filings with the Office of the Nevada Secretary of State, and the next steps are underway with FINRA for a symbol change to match the new name. The new symbol will be announced in the near term.
The company has also hired the accounting firm, Turner, Stone and Company, LLP to review and audit the Company's financials. "The OmniCanna Health Solutions name change will have no effect on the Company's share structure, corporate organization, business model operations, or corporate governance," according to a Tuesday release from the company.
By Steve Elliott
Less than two weeks after the U.S. House passed a measure that would defund Drug Enforcement Administration raids on medical marijuana dispensaries, reports have begun to surface of DEA agents intimidating physicians trying to work with state-legal dispensaries in Massachusetts.
At least four more Massachusetts doctors recently received visits from the DEA agents, bringing to seven the number who got an unexpected ultimatum from the DEA for authorizing patients to use medical marijuana.
Federal investigators told the doctors they would have to "sever ties" with medical marijuana dispensaries or risk losing their license to prescribe medications, reports Kay Lazar at MThe Boston Globe.
Already, some doctors have been forced to resign their advisory positions with dispensaries, which Massachusetts voters agreed in 2012 to allow.
A spokeswoman at the DEA's headquarters in Washington, D.C., refused requests for an interview. The agency on Friday released a terse statement.
Arizona On the Road to Becoming 12th State to Provide PTSD Patients Access to Medical Marijuana
Veterans, Medical Professionals and Advocates Winning in Three Year Quest To Change Arizona Law and Acknowledge Medical Marijuana’s Benefit for PTSD
After years of hard-fought efforts a coalition of patients, medical professionals, and advocates succeeded in demonstrating the medical safety and efficacy of marijuana for post-traumatic stress disorder (PTSD), according to the Administrative Law Judge who heard the case. The Arizona Dept. of Health has denied all petitions submitted previously.
On Wednesday, June 4, Judge Thomas Shedden issued his ruling saying that “a preponderance of evidence shows medical marijuana provides palliative benefit to those suffering from PTSD.” The decision is now in the hands of Will Humble, director of Arizona Dept. of Health Services; Humble has until July 9 to accept or appeal Judge Shedden’s decision.
The Drug Policy Alliance’s Freedom to Choose campaign, which advocates for veterans’ access to medical marijuana contributed a compilation of published studies and personal testimony from psychiatrists in New Mexico and veterans who use medical marijuana to alleviate symptoms of PTSD.
By Steve Elliott
"Don't be shy," says Amish Parikh, vice president of My Compassion, a Michigan-based nonprofit hosting a medical marijuana conference this weekend in Chicago. "It's OK to talk about marijuana -- cannabis."
As Illinois' medicinal cannabis rules are being finalized, the Chicago Cannabis Conference 2014 is being held this weekend, June 7-8 at Navy Pier. It will feature experts, advocates and businesspeople speaking about issues from the medicinal uses of cannabis to how to cook with pot.
According to Parikh, his group includes a consultant, a doctor and a nonprofit executive. They plan to use the conference to boost awareness of the medical benefits of marijuana, and to boost its image.
"If you respect the law, the law will stay," Parikh said. "We're trying to teach that as well."
Dr. Herman Toney, a medical marijuana advocate, will be joined at the conference by medical and scientific experts including naturopath Dr. Rob Streisfold, pediatrician Dr. Roberet Hicks, and cannabis researcher Dr. David Ostrow, reports Will Schutt at Medill Reports.
Panels will also be included where patients with brain cancer, leukemia, Crohn's, epilepsy and other conditions will speak about their experiences with medical marijuana.
By Steve Elliott
Alternaturals, Inc., on Thursday announced that it has chosen Kush Creams, a Washington-based medical marijuana grower and distributor, to manufacture and distribute what it is calling its new medicinal cannabis product, 5 Hour High.
According to the company, 5 Hour High is a shot-style drink, similar to the energy drinks found in convenience stores -- with one big difference. This juice-like drink delivers a dose of THC, marijuana's main psychoactive ingredient, that it says "has been specially formulated to improve mood and maintain energy levels."
The company said it expects non-smoking methods of ingesting THC to become more popular now that "many states have decriminalized the multi-billion dollar marijuana industry."
Alternaturals said it wants 5 Hour High to be sold in "most" medical marijuana dispensaries where medicinal consumption of cannabis is legal.
"We are extremely excited to be working with Kush Creams on this project because in an emerging market, you really have to go with the best if you want to have a long term stake in this industry," said Emmanual Gyamfi, CEO at Alternaturals. "We haven't found another company like them, and we are confident that we will both be very successful with this product line."
By Steve Elliott
South Carolina Governor Nikki Hayley on Monday signed into law a bill to allow limited access to marijuana-derived cannabidiol (CBD) oil.
Senate Bill 1035 is written to allow children with severe epilepsy-related seizures to use CBD oil, a non-psychoactive component of cannabis, to quell their seizures if authorized by a doctor, reports Celeste Stiles at The Daily Chronic.
The new law establishes a clinical trial at the Medical University of South Carolina to assess the effectiveness of CBD in controlling seizures. MUSC will also be responsible for supplying all the CBD oil for the program.
It is unclear when, if ever, CBD oil will actually become available to sick kids.
The bill passed unanimously in the South Carolina Senate, and by a lopsided 92-5 vote in the House; these vote totals show what low political risk CBD bills have become, even in conservative states. CBD is politically safe because, as a non-psychoactive component of cannabis, it doesn't get anyone high, and better yet, it helps to quell seizures of the kind often found in pediatric epilepsy.
So the combination of "helping kids" and "it doesn't get you high" has proven an "in" for medical marijuana in what would otherwise have been quite forbidding places, such as the halls of power in Georgia, Alabama, Mississippi, Tennessee, Utah, Iowa, Wisconsin, Kentucky, and now South Carolina.
By Steve Elliott
Tennessee Governor Bill Haslam signed a very limited, CBD-only, medical marijuana "study" bill into law last Friday. Sadly, the bill may not ever result in relief for any patients at all.
Senate Bill 2531 creates a four-year study on the medicinal benefits of cannabidiol (CBD), a non-psychoactive component of marijuana, reports the Marijuana Policy Project. The bill specifies that Vanderbilt University will conduct the study, and Tennessee Tech will theoretically grow the cannabis.
As has been the case with similarly weak "CBD-only" legislation passed in other conservative states recently, the many limitations of the bill mean it won't result in relief for patients; Tennessee hasn't become a "medical marijuana state" by any stretch of the imagination.
The law foolishly depends on the cooperation of the Drug Enforcement Administration (DEA) in authorizing the cultivation of marijuana in Tennessee for the study; it's as if those who wrote the bill haven't bothered to inform themselves of the fact that the DEA has never authorized anyone except The University of Mississippi to grow cannabis for the past 50 years.
CBD-only laws leave most potential medical marijuana patients to suffer. CBD has been found effective in quelling seizures, but those treating seizure disorders with medical marijuana are only a small percentage of total patients who could benefit from cannabis.
Patient advocates are producing ads in an effort to educate public, hold federal policymakers accountable
The medical marijuana advocacy group Americans for Safe Access (ASA) is running 30-second TV advertisements on MSNBC in Maryland and South Florida over the next few days to draw attention to Members of Congress who opposed medical marijuana reform in last week's House vote.
One of the ads focuses on Rep. Andy Harris (R-MD), who spoke out on the House floor against a measure that restricts Justice Department funds spent on medical marijuana enforcement in states that have legalized its use. Despite the recent passage of a medical marijuana law in his State of Maryland, Rep. Harris made the claim Friday that "Marijuana is neither safe nor legal."
The other ad focuses on Democratic National Committee Chair, Rep. Debbie Wasserman Schultz (D-FL), who was one of only 18 House Democrats to vote against the medical marijuana measure last week. Notably, Rep. Wasserman Schultz voted contrary to several other Democrats in her South Florida delegation.
Two Northern California medical marijuana dispensaries have announced they will be giving away free high-CBD tincture medication for children suffering from seizure disorders.
In the wake of the recent death of 6-year old Charlee Nelson in Utah after she was denied cannabis extract known to help control seizures caused by a neurological disorder, Dave Spradlin, co-director of Magnolia Wellness in Oakland and River City Phoenix in Sacramento, has announced that he will provide for free the expensive extract to any patients with a similar ailment.
The medicine is a scientifically produced liquid made from marijuana plants and used to treat people with severe seizure disorders. The tincture is rich in a chemical called cannabidiol, or CBD, but low in THC, the main psychoactive ingredient in marijuana.
CBD is a non-psychoactive component of marijuana that is known to possess a wide range of therapeutic benefits. It has proven to be especially effective in the treatment of seizures brought on by neurological conditions such as Batten disease, which was blamed in the death of Charlee Nelson.
“People are really suffering and this product has been known to cut seizures from hundreds a day to just a few a week or none at all,” said Spradlin.
Many in the medical community feel this is an effective alternative to conventional pharmaceuticals and can dramatically improve a patient’s quality of life.
Senate Leadership is Holding Up a Vote on the Bill, Leaving Sick New Yorkers to Needlessly Suffer
Senate Refuses to Act on Bill Supported by More Than 80% of New York Voters and Thousands of New York Patients, Doctors and Caregivers
Parents of children with epilepsy and patients living with multiple sclerosis and other serious, debilitating medical conditions will rally on Wednesday at the Rockville Centre LIRR station across from Senate Co-president Dean Skelos’ office to demand a vote on the Compassionate Care Act in the New York Senate.
The bill (S.4406-B/Savino and A.6357-B), which would create one of the nation’s most tightly regulated medical marijuana programs, would allow seriously ill patients access to a small amount of marijuana under the supervision of their healthcare provider.
Earlier this month, the Assembly passed the bill for the fifth time with broad bipartisan support. The bill has also passed through the Senate Health Committee and is now awaiting a vote in the Senate Finance Committee.
The Senate bill sponsor, Senator Diane Savino, has said she has more than enough votes to pass the bill if it comes to the floor for a vote. But thus far, the Senate Majority Coalition Leaders -- Senator Skelos and Senator Klein –- have not allowed the bill to the floor of the Senate for a vote.
If the vote does not take place before the session ends on June 19, patients and caregivers will be forced to wait another year for legal relief.
What: Rally with caregivers and patients to support the Compassionate Care Act
New York: Medical Marijuana Patients, Physicians Outraged; Governor Proposes Leaving Patients BehindSubmitted by steveelliott on Tue, 06/03/2014 - 16:48
Comprehensive Legislation is Needed to Relieve Suffering in New York; Research Should Augment, Not Replace, Legislative Solution
Strong Statements from Patients, Caregivers and Physicians Calling on Governor to Support Compassionate Care Act
The Buffalo News on Tuesday reported on an agreement with Britain-based GW Pharmaceuticals to pursue clinical trials in New York for Epidiolex, a investigational new marijuana-derived drug that is intended for children with severe seizure disorders. The proposal is limited to research studies only, must go through the lengthy FDA-approval process, and would be focused solely on children under 18 years of age with severe seizure disorders who have not responded to other medications.
The research study is not the same thing as a patient access system for medical marijuana, such as the one as outlined in the Compassionate Care Act (S.4406B-Savino/A.6357B-Gottfried). The research trials would not allow eligible patients in New York to access medical marijuana under the supervision of their healthcare provider.
Rather, only a very small, select group patients -- likely limited to a few dozen -- who qualify for the research trial would be allowed access into the study.
Patients, caregivers and physicians, frustrated with Gov. Cuomo’s failure to support real solutions, reacted strongly to the proposed "trials."
Republican Support for Medical Marijuana Builds After GOP-Led U.S. House of Representatives Passes Bipartisan Bill Directing Feds to Respect State Marijuana Laws
Patients, Families and Advocates Cheer Maziarz and New York Times Editorial, Travel to Albany Monday to Demand Vote in Senate Finance Committee
In a another strong sign of growing GOP support for medical marijuana, new York State Senate Vice President Pro Tempore George Maziarz (R-Lockport) has signed on as co-sponsor of the Compassionate Care Act ( S.4406-B (Savino)), which would allow eligible patients with serious and debilitating conditions to access medical marijuana under the supervision of their healthcare provider.
In February, Maziarz became one of the first Senate Republicans to publicly announce his support for the Compassionate Care Act along with Senators Grisanti and Robach. Since then then, they’ve been joined by O’Mara, Bonacic and Larkin, who also announced their support. Maziarz, the third-highest ranking member of the Senate Republicans, joins Sen. Robach and Grisanti as Republican a co-sponsor.
Patients, healthcare providers and advocates with the statewide Compassionate Care NY coalition praised Sen. Maziarz and called on Senate leadership to finally allow a vote on the measure.
By Steve Elliott
The fate of a medical marijuana bill in New York is still unresolved, where the Assembly has approved legislation, but a similar measure remains stalled in the Senate, despite the votes apparently being there to pass it.
Advocates cheered last week as the Assembly approved the Compassionate Care Act, which would permit authorized patients to possess small amounts of cannabis, reports Karen DeWitt at WRVO. The legislation would also set up licensed dispensaries to grow and sell medical marijuana.
"This is the group that I'm most concerned with, Mr. Speaker," said Assemblyman Kevin Cahill, who voted with the majority of Democrats in favor, saying the measure would give law abiding citizens access to much-needed medicine. "Those people who will not even entertain the notion of the illegal use of marijuana just because it is illegal, not because it is not efficacious."
The measure did win some converts on the Republican side of the aisle. Assemblyman Steve Katz, who had voted against the bill in the past, voted for it this time after being stopped by police for allegedly possessing marijuana. The charges were later dropped, but Katz has become a cannabis advocate, even investing in some businesses operating in states where it is legal.
"Over the past year, I've gone above and beyond to explore the beneficial aspects of medicinal cannabis and the surrounding industry," Katz said.